DogStem

Preliminary results

The results of the clinical trial are based on the study of the lameness in a plate-force platform as primary endpoint. This test allows us to evaluate the evolution of lameness objectively, comparing the weight that the animal carries on each limb and thus being able to assign a numerical value to the degree of lameness.

The use of tools that make it possible to transform a typically subjective measure such as pain and lameness into a quantitative variable by force platform gives robustness to the results that have been rare until now.

DogStem does not seek only a partial improvement, but a substantial improvement in the quality of life and reduction of pain

Lameness reduction

Preliminary results show that 65% of the dogs treated with DogStem improved their gait analysis on the plate- force, demonstrating a lower degree of lameness and joint pain, whereas no dog treated with placebo improved their gait analysis.

%

SUCCESS OF THE TREATMENT GROUP

%

SUCCESS OF THE PLACEBO GROUP

Orthopedic Assessment

collaborating hospitals carry out an orthopedic evaluation at different times after the infiltration.

In addition to the objective evaluation by force platform, the specialist traumatologists of our collaborating hospitals carry out an orthopedic evaluation at different times after the infiltration. In the orthopedic examination performed, 93% of the patients treated with stem cells showed improvement in the infiltrated joint, compared to a placebo effect of 49%.

%

IMPROVEMENT OF THE TREATMENT GROUP

%

IMPROVEMENT OF THE PLACEBO GROUP